News Release 

Treatment of opioid use disorder among commercially insured patients in context of COVID-19 pandemic

JAMA

Research News

What The Study Did: Opioid use disorder treatment during the early months of the COVID-19 pandemic, including medication fills, outpatient visits and urine tests among privately insured individuals, was compared with 2019 in this study.

Authors: Haiden A. Huskamp, Ph.D., of Harvard Medical School in Boston, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2020.21512)

Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.21512?guestAccessKey=07d7e6a6-d1c1-4ab2-a9a8-220eeb6674e2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121520

###

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.